Recent advances in inducible gene expression systems

Current Opinion in Biotechnology

Volumn 9, Issue 5, 1998, Pages 451-456

  Rossi, Fabio M V ^a   Blau, Helen M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN; TACROLIMUS; TETRACYCLINE;

GENE CONTROL; GENE INDUCTION; GENE REPRESSION; GENE THERAPY; GENOTOXICITY; GROWTH DISORDER; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TRANSCRIPTION REGULATION;

ANIMALIA; EUKARYOTA;

EID: 0032192146     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(98)80028-1     Document Type: Article

References (36)

1. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA. 89:1992;5547-5551.
2. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science. 268:1995;1766-1769.
3. Bello B, Resendez-Perez D, Gehring WJ. Spatial and temporal targeting of gene expression in Drosophila by means of a tetracycline-dependent transactivator system. Development. 125:1998;2193-2202.
4. Mayford M, Bach ME, Huang YY, Wang L, Hawkins RD, Kandel ER. Control of memory formation through regulated expression of a CaMKII transgene. Science. 274:1996;1678-1683.
5. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lubbert H, Bujard H. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA. 93:1996;10933-10938.
6. Saez E, No D, West A, Evans RM. Inducible gene expression in mammalian cells and transgenic mice. Curr Opin Biotechnol. 8:1997;608-616.
7. Garrick D, Fiering S, Martin DI, Whitelaw E. Repeat-induced gene silencing in mammals. Nat Genet. 18:1998;56-59.
8. Ackland-Berglund CE, Leib DA. Efficacy of tetracycline-controlled gene expression is influenced by cell type. Biotechniques. 18:1995;196-200.
9. Howe JR, Skryabin BV, Belcher SM, Zerillo CA, Schmauss C. The responsiveness of a tetracycline-sensitive expression system differs in different cell lines. J Biol Chem. 270:1995;14168-14174.
10. Gossen M, Bujard H. Efficacy of tetracycline-controlled gene expression is influenced by cell type: commentary. Biotechniques. 19:1995;213-216.
11. O'Brien K, Otto K, Rao RN. Construction and characterization of a one-plasmid system for the controlled expression of genes in mammalian cells by tetracycline. Gene. 184:1997;115-120.
12. Liang X, Hartikka J, Sukhu L, Manthorpe M, Hobart P. Novel, high expressing and antibiotic-controlled plasmid vectors designed for use in gene therapy. Gene Ther. 3:1996;350-356.
13. Mohammadi AS, Hawkins RE. Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory system. Gene Ther. 5:1998;76-84.
14. Hofmann A, Nolan GP, Blau HM. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc Natl Acad Sci USA. 93:1996;5185-5190.
15. Hwang JJ, Scuric Z, Anderson WF. Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline-responsive expression system. J Virol. 70:1996;8138-8141.
16. Iida A, Chen ST, Friedmann T, Yee JK. Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system. J Virol. 70:1996;6054-6059.
17. Lindemann D, Patriquin E, Feng S, Mulligan RC. Versatile retrovirus vector systems for regulated gene-expression in-vitro and in-vivo. Mol Med. 3:1997;466-476.
18. Paulus W, Baur I, Boyce FM, Breakefield XO, Reeves SA. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol. 70:1996;62-67.
19. Hoshimaru M, Ray J, Sah DW, Gage FH. Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene. Proc Natl Acad Sci USA. 93:1996;1518-1523.
20. Sah DW, Ray J, Gage FH. Bipotent progenitor cell lines from the human CNS. Nat Biotechnol. 15:1997;574-580.
21. Bohl D, Naffakh N, Heard JM. Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nat Med. 3:1997;299-305.
22. Deuschle U, Meyer WK, Thiesen HJ. Tetracycline-reversible silencing of eukaryotic promoters. Mol Cell Biol. 15:1995;1907-1914.
23. Hinrichs W, Kisker C, Duvel M, Muller A, Tovar K, Hillen W, Saenger W. Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance. Science. 264:1994;418-420.
24. 2+ reveals mechanism of antibiotic resistance. J Mol Biol. 247:1995;260-280.
25. Spencer DM, Wandless TJ, Schreiber SL, Crabtree GR. Controlling signal transduction with synthetic ligands. Science. 262:1993;1019-1024.
26. Belshaw PJ, Ho SN, Crabtree GR, Schreiber SL. Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc Natl Acad Sci USA. 93:1996;4604-4607.
27. Rivera VM, Clackson T, Natesan S, Pollock R, Amara JF, Keenan T, Magari SR, Phillips T, Courage NL, Cerasoli F Jr, et al. A humanized system for pharmacologic control of gene expression. Nat Med. 2:1996;1028-1032.
28. Pomerantz JL, Sharp PA, Pabo CO. Structure-based design of transcription factors. Science. 267:1995;93-96.
29. Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS, Schreiber SL. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature. 369:1994;756-758.
30. Magari SR, Rivera VM, Iuliucci JD, Gilman M, Cerasoli F Jr. Pharmacologic control of a humanized gene therapy system implanted into nude mice. of special interest J Clin Invest. 100:1997;2865-2872 In this paper, the authors show that it is possible to predict to a large extent the in vivo dosage of a human growth hormone transgene under the control of the rapamycin inducible system. This elegant analysis also points to some of the limitations of the system in its current form, such as the slow kinetics of downregulation of the expression upon rapamycin withdrawal.
31. Liberles SD, Diver ST, Austin DJ, Schreiber SL. Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. of special interest Proc Natl Acad Sci USA. 94:1997;7825-7830 This study describes the synthesis of rapamycin analogues that still bind FKBP12 but have lost the ability to bind the wild-type FRB from hFRAP. Furthermore, it describes the identification of FRB mutants that can be bound by these compounds by a three hybrid yest assay. Unlike rapamycin, these compounds should not be immunosuppressive and should thus prove useful to induce expression of exogenous genes in vivo.
32. Ho SN, Biggar SR, Spencer DM, Screiber SL, Crabtree GR. Dimeric ligands define a role for transcriptional activation domains in reinitiation. Nature. 382:1996;822-826.
33. Fiering S, Northrop JP, Nolan GP, Mattila PS, Crabtree GR, Herzenberg LA. Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T-cell antigen receptor. Genes Dev. 4:1990;1823-1834.
34. Ko MS, Nakauchi H, Takahashi N. The dose dependence of glucocorticoid-inducible gene expression results from changes in the number of transcriptionally active templates. EMBO J. 9:1990;2835-2842.
35. Kringstein AM, Rossi FMV, Hofmann A, Blau H. Graded transcriptional response to different concentrations of a single transactivator. Proc Natl Acad Sci USA. 1998;. in press.
36. Spicher A, Guicherit OM, Duret L, Aslanian A, Sanjines EM, Denko NC, Giacia AJ, Blau H. Highly conserved RNA sequences that are sensors of environmental stress. Mol Cell Biol. 1998;. in press.